NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 86 filers reported holding NEXTCURE INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,158,557 | -30.4% | 898,106 | -2.9% | 0.00% | – |
Q2 2023 | $1,665,577 | +21.7% | 925,320 | +0.1% | 0.00% | – |
Q1 2023 | $1,368,147 | -7.3% | 924,423 | -11.7% | 0.00% | – |
Q4 2022 | $1,475,939 | -56.9% | 1,046,766 | -16.0% | 0.00% | – |
Q3 2022 | $3,428,000 | -42.3% | 1,246,867 | -1.4% | 0.00% | – |
Q2 2022 | $5,943,000 | -3.4% | 1,264,540 | -0.1% | 0.00% | – |
Q1 2022 | $6,154,000 | -17.4% | 1,266,114 | +1.9% | 0.00% | – |
Q4 2021 | $7,452,000 | -10.1% | 1,242,133 | +1.0% | 0.00% | – |
Q3 2021 | $8,290,000 | -14.3% | 1,230,001 | +2.1% | 0.00% | – |
Q2 2021 | $9,675,000 | -55.2% | 1,204,689 | -44.2% | 0.00% | -100.0% |
Q1 2021 | $21,602,000 | +30.8% | 2,158,166 | +42.5% | 0.00% | 0.0% |
Q4 2020 | $16,510,000 | +52.7% | 1,514,643 | +23.3% | 0.00% | – |
Q3 2020 | $10,813,000 | -53.6% | 1,228,792 | +13.2% | 0.00% | -100.0% |
Q2 2020 | $23,282,000 | -43.5% | 1,085,841 | -2.4% | 0.00% | -50.0% |
Q1 2020 | $41,222,000 | -33.6% | 1,112,009 | +0.9% | 0.00% | 0.0% |
Q4 2019 | $62,087,000 | +739.7% | 1,102,206 | +359.9% | 0.00% | – |
Q3 2019 | $7,394,000 | +263.9% | 239,668 | +76.6% | 0.00% | – |
Q2 2019 | $2,032,000 | – | 135,701 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |